- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06022393
CBT Training for Cognitive Reappraisal as an Intervention for Patients With Functional Tremor - an EEG Study
CBT-Training Zur Kognitiven Umbewertung Als Lntervention Bei Patienten*Innen Mit Funktionellem Tremor - Eine EEG-Studie
The aim of this psychological study is to evaluate the effect of a cognitive behavioral therapy (CBT) intervention aimed at improving cognitive reappraisal on (1) Clinical and Self-Rated Health according to Patient Global Impression-Change (PGI-C), Patient Global Impression-Severity (PGI-S), Clinical Global Impression-Change (CGI-C) and Clinical Global Impression-Severity (CGI-S) after 4 weeks, (2) the change in the severity of the functional movement disorder/tremor as assessed by a blinded clinician using the Simplified Version of the Psychogenic Movement Disorders Rating Scale (S-FMDRS) after 4 weeks and (3) the change in the severity of functional tremor assessed via the Fahn Tolosa Marin Tremor Rating Scale (FTM) after 4 weeks.
The knowledge gained about the introspective and neurobiological effect of this cognitive behavioral therapy intervention should enable improved therapy options for patients with functional tremor / functional motor disorders in the future.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an intervention study including patients of the outpatient clinic for movement disorders at the University Clinic of Neurology in Graz.
The patients will randomly be assigned to the intervention (cognitive reappraisal) or control (reflection) group.
The study consists of a first preliminary examination at the University clinic, followed by an electroencephalogram (EEG)-lab-session at the Institute of Psychology of the Karl-Franzens-University of Graz. The patients will complete emotion-regulation tasks while the EEG is conducted and then be introduced to an App, with which they will either complete 14 cognitive-reappraisal-tasks (intervention) or 14 reflection-tasks (control) within the next 4 weeks. A task will need to be completed in the App once every two days.
After this training period, there will be a second preliminary examination at the University Clinic as well as a second subsequent EEG-lab-sessions at the Institute of Psychology at the Karl-Franzens-University.
In addition, after two weeks of training, the patients will receive a short phone call and will be asked to complete the PGI-S and PGI-C.
Questionnaires completed during the first preliminary examination:
- CGI-S - Clinical Global Impression - severity
- PGI-S - Patient Global Impression - severity
- FTM - Fahn Tolosa Marin Tremor Rating Scale
- S-FMDRS - Simplified Version of the Psychogenic Movement Disorders Rating Scale
Questionnaires completed during the first EEG-lab-session:
- VKT - Verbal creativity test
- RIT - Reappraisal Inventiveness Test
- ERQ - Emotion Regulation Questionnaire
- LPFS-BF - Level of Personality Functioning Scale:
- SF-36 - Short Form (36)
- EQ-5D-5L - Health Questionnaire
- PAHD - Psychosomatic Assessment Health-DISC
Questionnaires completed during the second preliminary examination:
All the questionnaires also used in the first examination plus:
- CGI-C - Clinical Global Impression - Change
- PGI-C - Patient Global Impression - Change
Questionnaires completed during the second EEG-lab-session:
The same as in the first EEG-lab-session.
4 weeks after the completion of the last EEG-lab-session, the patients will receive another short phone-call in which they will again be asked to complete the PGI-S and PGI-C.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Styria
-
Graz, Styria, Austria, 8010
- Medical University of Graz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of a functional movement disorder
Exclusion Criteria:
- The patient is not capable of giving consent.
- The patient does not have sufficient knowledge of German to answer the questionnaires (questionnaires are only available in German).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Reappraisal
The intervention group completes CBT-training to improve their cognitive reappraisal and emotion-regulation-skills.
|
Patients complete 14 tasks on an app in a time span of 4 weeks in which they are asked to cognitively reappraise fear or anger inducing situations and are encouraged to implement this strategy into their daily lifes.
|
|
Sham Comparator: Reflection
The control group completes tasks based on reflection about their daily lifes, which should have no impact on their emotion-regulation-skills or functional motor disorder.
|
Patients complete 14 tasks on an app in a time span of 4 weeks in which they are asked to reflect on certain topics of their day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Clinical health - Clinical Global Impression Severity Scale
Time Frame: 4 weeks
|
Clinical health according to Clinical Global Impression of Severity Scale (CGI-S) rated by a medical professional. Three questions regarding patients current mood, influence of the symptoms on everyday motor function and overall severity. Answer options:
|
4 weeks
|
|
Change in Clinical health - Clinical Global Impression of Change
Time Frame: 4 weeks
|
Clinical health according to Clinical Global Impression of Change Scale (CGI-C) rated by a medical professional. Three questions regarding patients mood, everyday motor function and overall change as well as a rating regarding the relevance of the change (Yes or No). Answer options: Very Much worse Much worse Slightly worse No change Marginally better Much better Very Much better Higher values = better outcome |
4 weeks
|
|
Change in Self-assessed health - Patient Global Impression Severity Scale
Time Frame: 4 weeks
|
Self-assessed health according to Patient Global Impression of Severity Scale (PGI-S) rated by the patients themselves. Three questions regarding patients current mood, influence of the symptoms on everyday bodily function and overall severity. Answer options:
|
4 weeks
|
|
Change in Self-assessed health - Patient Global Impression of Change
Time Frame: 4 weeks
|
Self-assessed health according to Patient Gloabal Impression of Change Scale (PGI-C) rated by the patients themselves. Three questions regarding patients mood, everyday bodily function and overall change as well as a rating regarding the relevance of the change (Yes or No). Answer options: Very Much worse Much worse Slightly worse No change Marginally better Much better Very Much better Higher values = better outcome |
4 weeks
|
|
The change in severity of the functional movement disorder
Time Frame: 4 weeks
|
The change in severity as assessed by a blinded clinician using the severity of the functional movement disorder by means of the Simplified Version of the Psychogenic Movement Disorders Rating Scale (S-FMDRS).
Scoring: 0-3, higher values indicate worse outcome.
|
4 weeks
|
|
The change in tremor severity
Time Frame: 4 weeks
|
The change in tremor severity assessed using the Fahn Tolosa Marin Tremor-Rating-Scale. Scoring: 0-4, higher values indicate worse outcome. |
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the ability of emotion regulation
Time Frame: 4 weeks
|
The change in the ability of emotion regulation assessed using the Emotion Regulation Questionnaire. High scores on the reassessment scale suggest that the person is more likely to use cognitive strategies to change the emotional meaning of situations. This may be associated with better emotional adaptability and well-being. High scores on the suppression scale indicate that the person is more inclined to suppress or avoid the expression of emotions. This may be associated with lower emotional adaptability and well-being. |
4 weeks
|
|
Changes in patients EEG-activity.
Time Frame: 4 weeks
|
Training-based changes in patients' EEG activity will be assessed for a) tasks-related changes in EEG alpha frequency power (TRPs) as well as b) frontal alpha asymmetry changes during the generation of cognitive reappraisals.
Changes in these parameters should unterline behavioral changes in reappraisal success, divergent thinking, and executive functioning.
Moreover, we will look at c) the EEG theta/beta frequency ratio to map changes in stress coping, emotion regulation, and behavioral flexibility.
|
4 weeks
|
|
Change in the patients Creativity
Time Frame: 4 weeks
|
The change in creativity assessed using the Verbal Creativity Test.
No Minimum or Maximum values, higher score = better outcome.
|
4 weeks
|
|
Change in the patients Welfare- Health Questionnaire EQ-5D-5L.
Time Frame: 4 weeks
|
The change in the patients welfare assessed using the Health Questionnaire EQ-5D-5L. 5 Level, Scores: 1-5, higher values indicate worse outcome. 1 overall Scale: 0-100, higher values indicate better outcome. |
4 weeks
|
|
Change in the patients Welfare- Short Form Health Questionnaire
Time Frame: 4 weeks
|
The change in the patients welfare assessed using the Short Form Health Questionnaire. The possible score ranges from 0 to 100 points, with 0 points representing the greatest possible restriction of health, while 100 points indicate no health restriction. |
4 weeks
|
|
Change in the patients Welfare - Psychosomatic Assessment Health-DISC. Minimum value in each section: 0 Maximum value in each section: 10 Higher scores = better outcome.
Time Frame: 4 weeks
|
The change in the patients welfare assessed using the Psychosomatic Assessment Health-DISC 6 Levels, Scores: 0-10, higher values indicate better outcome.
|
4 weeks
|
|
Change in patients personality and behavioral aspects
Time Frame: 4 weeks
|
The change in patients personality and behavioral aspects assessed using the Level of Personality Functioning Scale. The items are on a 4-point Likert scale from 1 ("doesn't apply at all") to 4 ("applies exactly") to"). The evaluation is carried out by means of summaries, so that values on the Overall scale: 12 - 48 Subscales Self and Interpersonal: 6 - 24 |
4 weeks
|
|
Long-term change in Self-assessed health - Patient Global Impression of Change
Time Frame: 8 weeks
|
Self-assessed health according to Patient Global Impression of Change Scale (PGI-C) rated by the patients themselves. Three questions regarding patients mood, everyday bodily function and overall change as well as a rating regarding the relevance of the change (Yes or No). Answer options: Very Much worse Much worse Slightly worse No change Marginally better Much better Very Much better Higher values = better outcome |
8 weeks
|
|
Long-term change in Self-assessed health - Patient Global Impression Severity Scale
Time Frame: 8 weeks
|
Self-assessed health according to Patient Global Impression of Severity Scale (PGI-S) rated by the patients themselves. Three questions regarding patients current mood, influence of the symptoms on everyday bodily function and overall severity. Answer options:
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Corinna Perchtold-Stefan, PhD, University of Graz
- Study Chair: Petra Schwingenschuh, MD, Medical University of Graz
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35-315 ex 22/23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Movement Disorder
-
Medical University of GrazRecruitingFunctional Neurological Disorder | Functional Movement DisorderAustria
-
Fundación Pública Andaluza para la gestión de la...Fundación CaserCompletedFunctional Neurological Disorder | Functional Movement DisorderSpain
-
University of VirginiaChild Neurology FoundationActive, not recruitingFunctional Neurological Symptom Disorder | Functional Neurological Disorder | Functional Movement DisorderUnited States
-
Western University, CanadaNot yet recruitingFunctional Movement DisorderCanada
-
Western University, CanadaNot yet recruitingFunctional Movement DisorderCanada
-
Western University, CanadaNot yet recruiting
-
The Cleveland ClinicCompletedFunctional Movement DisorderUnited States
-
Western University, CanadaNot yet recruiting
-
University of AmericasActive, not recruitingFragility | Functional Movement DisorderChile
-
National Institute of Neurological Disorders and...Active, not recruitingFunctional Movement DisorderUnited States
Clinical Trials on Cognitive Reappraisal
-
University of DenverWake Forest UniversityRecruiting
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedSelf Injurious Behavior Without Suicidal IntentUnited States
-
University of ViennaRecruitingMedically Unexplained Symptoms | Impairment | Persistent Physical Symptoms | Somatic Symptom Disorder (DSM-5) | Psychological FactorsAustria
-
Shenzhen Kangning HospitalScience and Technology Innovation Commission of Shenzhen MunicipalityNot yet recruiting
-
Palo Alto Veterans Institute for ResearchVA Palo Alto Health Care SystemCompletedDriving Distress Secondary to Trauma During DeploymentUnited States
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; RWTH Aachen University; University of AmsterdamCompletedMajor Depressive DisorderGermany
-
Virginia Commonwealth UniversityMind & Life FoundationCompleted
-
Asia UniversityCompletedDepressive Symptoms | Anxiety Symptoms | Emotion RegulationTaiwan
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH); William Marsh Rice UniversityRecruitingBorderline Personality DisorderUnited States
-
Karolinska InstitutetCompletedInappropriate Anger ExpressionSweden